Fighting Antimicrobial Resistance Takes All of Us: Leveraging the NHSN AUR Module - On Demand
This activity will highlight differences between the 2024 and 2025 requirements for submitting AUR data for the CMS Promoting Interoperability Program. It will also explain the timeline for the AU Option SAAR rebaseline and outline the planned changes impacting hospitals using the SAARs. This activity will also demonstrate how to use the NHSN AUR Module data to inform and assess antibiotic stewardship activities.
Target Audience
- Nurses
- Physicians
- Pharmacists
- Pharmacy Technicians
- Other Healthcare Professionals
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Describe the differences between the 2024 and 2025 requirements for submitting AUR data for the CMS Promoting Interoperability Program
- Explain the timeline for the AU Option SAAR rebaseline and outline the planned changes impacting hospitals using the SAARs
- Demonstrate how to use the NHSN AUR Module data to inform and assess antibiotic stewardship activities
At the conclusion of this activity, pharmacists should be able to:
- Describe the differences between the 2024 and 2025 requirements for submitting AUR data for the CMS Promoting Interoperability Program
- Explain the timeline for the AU Option SAAR rebaseline and outline the planned changes impacting hospitals using the SAARs
- Demonstrate how to use the NHSN AUR Module data to inform and assess antibiotic stewardship activities
At the conclusion of this activity, pharmacy technicians should be able to:
- Describe the differences between the 2024 and 2025 requirements for submitting AUR data for the CMS Promoting Interoperability Program
- Explain the timeline for the AU Option SAAR rebaseline and outline the planned changes impacting hospitals using the SAARs
- Demonstrate how to use the NHSN AUR Module data to inform and assess antibiotic stewardship activities
FACULTY & PLANNERS
Amy Webb, MPH, CHES
Sr. Public Health Analyst, Lanatan Consulting Group, Contractor for the National Heatlhcare Safety Network
Centers for Disease Control and Prevention
Melinda Neuhauser, PharmD, MPH, FCCP
Pharmacist and Acute Care Lead, Office of Antibiotic Stewardship
Centers for Disease Control and Prevention
Stacy Lauderdale, PharmD, BCPS
Associate Vice President of Evidence-Based Medicine and Drug Information
Vizient, Inc.
Jackie Stokes, BBS
Pharmacy Services Manager
Vizient, Inc.
Tomas Villanueva, DO, MBA, FACPE, SFHM
Senior Principal Clinical Operations
Vizient, Inc.
Diana Scott Diana Scott, MHA, RN, CPHQ
Principal, Regulatory and Accreditation Consulting Services
Vizient, Inc.
Samantha Gordon, MS
CE Programs Manager
Vizient, Inc.
Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director, Continuing Education
Vizient, Inc.
DISCLOSURE
Disclaimer
Joint Accreditation Statement
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nurses (CNE)
This activity is designated for 1.0 contact hours.
Physicians (CME)
Vizient, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists (CPE)
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 General CE - Attendance
- If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
- This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
Required Hardware/software
The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.